Autologous or Donor Cytotoxic T-Lymphocytes in Treating Patients With Relapsed Epstein-Barr Virus-Associated Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Autologous or Donor Cytotoxic T-Lymphocytes in Treating Patients With Relapsed Epstein-Barr Virus-Associated Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00070226. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00070226

Locations


United States, Texas
	Dan L. Duncan Cancer Center at Baylor College of Medicine
	Houston, Texas, United States, 77030

Sponsors and Collaborators

Baylor College of Medicine

National Cancer Institute (NCI)

Investigators


Study Chair:	Helen E. Heslop, MD	Baylor College of Medicine